OTCMKTS:RDGL Advanced Medical Isotope (RDGL) Stock Price, News & Analysis $0.05 0.00 (-1.71%) As of 09/25/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and TrendsSEC Filings About Advanced Medical Isotope Stock (OTCMKTS:RDGL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get RDGL alerts:Sign Up Key Stats Today's Range$0.04▼$0.0550-Day Range$0.05▼$0.0652-Week Range$0.04▼$0.12Volume203,783 shsAverage Volume778,150 shsMarket Capitalization$22.67 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Advanced Medical Isotope Corporation is a medical technology company developing targeted radiation products for cancer treatment. Its primary product candidate is RadioGel™, an injectable brachytherapy device designed to deliver yttrium-90 radiation directly to solid tumors. The company’s approach is intended to provide localized treatment while limiting radiation exposure to surrounding healthy tissue. RadioGel is being developed for potential use in treating tumors that may be difficult to address with conventional external-beam radiation or surgery. The company has focused on advancing the product through research, regulatory development and clinical evaluation, although its product candidates remain subject to applicable regulatory approvals and clinical requirements. Advanced Medical Isotope is based in the United States and has historically concentrated on the development of radioisotope-based therapies rather than operating a broad commercial healthcare services business. Publicly available information about its commercial operations, geographic reach and current leadership is limited.AI Generated. May Contain Errors. Read More Advanced Medical Isotope Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScoreRDGL MarketRank™: Advanced Medical Isotope scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Advanced Medical Isotope. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Advanced Medical Isotope is -4.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Advanced Medical Isotope is -4.59, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.01% of the float of Advanced Medical Isotope has been sold short.Short Interest Ratio / Days to CoverAdvanced Medical Isotope has a short interest ratio ("days to cover") of 0.02, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Advanced Medical Isotope has recently increased by 219.26%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAdvanced Medical Isotope does not currently pay a dividend.Dividend GrowthAdvanced Medical Isotope does not have a long track record of dividend growth. News and Social Media0.6 / 5News SentimentN/A News SentimentAdvanced Medical Isotope has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.72 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for Advanced Medical Isotope this week, compared to 0 articles on an average week. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Advanced Medical Isotope insiders have not sold or bought any company stock.Percentage Held by Insiders18.50% of the stock of Advanced Medical Isotope is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsAdvanced Medical Isotope has minimal institutional ownership at this time.Read more about Advanced Medical Isotope's insider trading history. Receive RDGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Advanced Medical Isotope and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. RDGL Stock News HeadlinesVivos Inc. Announces Peer-Reviewed Publication Characterizing PrecisionGel™ Polymer Platform in Elsevier Journal of Drug Delivery Science and TechnologySeptember 3, 2026 | globenewswire.comVivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India's Nuclear Regulatory Authority for International Manufacturing CenterAugust 18, 2026 | globenewswire.comIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every dollar while paying savers just 0.04 percent interest. A new law, the GENIUS Act signed last summer, has cleared the way for a different kind of money to emerge this fall, one that could offer savings rates up to 6 percent. See what Ian King, Chief Strategist at Strategic Fortunes, has uncovered about this shift before it goes live.September 26 at 1:00 AM | Banyan Hill Publishing (Ad)Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update - CorrectionJuly 27, 2026 | globenewswire.comVivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate UpdateJuly 27, 2026 | globenewswire.comVivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Therapy™July 6, 2026 | globenewswire.comVivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® ManufacturingJune 11, 2026 | globenewswire.comVivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™June 5, 2026 | globenewswire.comSee More Headlines RDGL Stock Analysis - Frequently Asked Questions How have RDGL shares performed this year? Advanced Medical Isotope's stock was trading at $0.0689 at the beginning of 2026. Since then, RDGL shares have decreased by 33.4% and is now trading at $0.0459. How were Advanced Medical Isotope's earnings last quarter? Advanced Medical Isotope Corporation (OTCMKTS:RDGL) issued its quarterly earnings results on Monday, March, 30th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.02 million for the quarter. How do I buy shares of Advanced Medical Isotope? Shares of RDGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Advanced Medical Isotope own? Based on aggregate information from My MarketBeat watchlists, some other companies that Advanced Medical Isotope investors own include MannKind (MNKD), Agenus (AGEN), APA (APA), Bionano Genomics (BNGO), Churchill Capital Corp IV (CCIV) and Canopy Growth (CGC). Company Calendar Last Earnings3/30/2026Today9/26/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:RDGL CIK1449349 Webwww.radiogel.com Phone(509) 736-4000Fax509-736-4007Employees1Year Founded2006Profitability EPS (Trailing Twelve Months)($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.07 million Net Margins-3,637.37% Pretax Margin-3,636.36% Return on EquityN/A Return on Assets-144.13% Debt Debt-to-Equity RatioN/A Current Ratio48.85 Quick Ratio47.72 Sales & Book Value Annual Sales$70 thousand Price / Sales323.90 Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-2.30Miscellaneous Outstanding Shares493,960,000Free Float402,581,000Market Cap$22.67 million OptionableNot Optionable Beta-0.72 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (OTCMKTS:RDGL) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredThe end of AI data centers coming?Marc Chaikin's Power Gauge system flagged Micron before it soared 970 percent, Celestica before a 6,600 percen...Chaikin Analytics | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredDid you forget to grab this?Most beginners stay stuck on the sidelines for years because no one shows them the simple steps between being ...Profits Run | Sponsored6 Elon Musk companies. The 1 FREE investor roadmap to them all.Elon Musk owns six companies, but most investors can only access four. Tesla, SpaceX, xAI, and X are public an...Zacks | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Advanced Medical Isotope Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Advanced Medical Isotope With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RDGL Stock Alerts